The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, W.
Right arrow Articles by Khoury, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, W.
Right arrow Articles by Khoury, S. J.
The Journal of Immunology, 1998, 160: 1504-1508.
Copyright © 1998 by The American Association of Immunologists

Mechanisms of Acquired Thymic Tolerance In Vivo: Intrathymic Injection of Antigen Induces Apoptosis of Thymocytes and Peripheral T Cell Anergy1

Wanjun Chen2,*, Mohamed H. Sayegh3,{dagger} and Samia J. Khoury4,*

* Center For Neurologic Diseases, and {dagger} Laboratory of Immunogenetics and Transplantation, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Intrathymic injection of Ag induces Ag-specific tolerance in several clinically relevant experimental autoimmune and transplantation models. However, the exact mechanisms of acquired thymic tolerance in vivo remain unclear. We investigated the mechanisms of acquired thymic tolerance in mice that are transgenic for the TCR specific for peptide 323-339 of OVA. Intrathymic injection of OVA leads to apoptosis of thymocytes starting as early as 3 h after injection and persisting up to 7 days. Double positive thymocytes undergo apoptosis earlier than single positive thymocytes, and significantly higher percentages of double positive thymocytes ultimately die as compared with single positive cells. Apoptotic cells show decreased surface expression of CD4. In the periphery, T cells from intrathymically injected animals had suppressed proliferation and IL-2 production to OVA compared with T cells from control Ag-injected mice. We conclude that intrathymic injection of Ag induces apoptosis of immature thymocytes and a subpopulation of mature thymocytes and induces prolonged anergy in peripheral T cells in vivo. Understanding the mechanisms of acquired thymic tolerance may lead to development of novel clinical strategies to prevent autoimmune disease and transplant rejection.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Injection of Ag in the thymus of adult animals induces Ag-specific tolerance in experimental transplantation (1, 2, 3) as well as in autoimmune models (4, 5, 6, 7, 8). We have previously shown that injection of guinea pig myelin basic protein or its encephalitogenic peptide (p71-90) into the thymus induces systemic tolerance and prevents the development of experimental autoimmune encephalomyelitis in the Lewis rat model (7) and that thymic dendritic cells mediate the effects of acquired thymic tolerance (9). In a mouse model, we have recently shown that intrathymic injection of Ag leads to Ag-specific suppression of proliferation and cytokine production and to failure of clonal expansion of Ag-specific T cells in vivo (10). The effector mechanisms mediating acquired thymic tolerance after intrathymic injection of Ag remain unclear, although anergy and deletion have been suggested as potential mechanisms (3, 10, 11, 12, 13).

Systemic administration of high doses of Ag induces tolerance by apoptosis of Ag-specific T cells in the thymus (14, 15). In this study, we used TCR-transgenic mice specific for peptide 323-339 of chicken OVA (14) to investigate the effector mechanisms of acquired thymic tolerance. Our data show that intrathymic injection of OVA induces deletion of some thymocytes and prolonged peripheral T cell anergy in vivo.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Animals

The DO11.10 transgenic mice expressing TCR with specificity for chicken OVA peptide 323-339 were kindly provided by Dr. D.Y. Loh (Washington University School of Medicine, St. Louis, MO) (14). The mice were extensively backcrossed onto BALB/c background and were bred and screened for expression of TCR transgenes by mAb KJ1-26 or mAb to Vß 8, as previously described (14); virtually all thymocytes in these mice express the transgene and all peripheral T cells are CD4+ KJ1-26+. Mice were maintained under specific pathogen-free conditions at Brigham and Women’s Hospital animal facility and were used at 8 to 12 wk of age.

Abs and reagents

FITC-conjugated CD8 (rat IgG2a), FITC or phycoerythrin (PE)5 -conjugated CD4 (rat IgG2a), and their respective isotype control anti-murine Abs were purchased from Caltag Laboratory (San Francisco, CA). Chicken OVA and hen egg lysozyme (HEL) were purchased from Sigma (St. Louis, MO). 7-Amino-actinomycin D (7-AAD), purchased from Calbiochem (La Jolla, CA), was dissolved at 5 mg/ml with 100% ethanol and stored at -20°C.

Intrathymic injection

Mice were injected intrathymically with 100 µg of chicken OVA or HEL dissolved in 50 µl of sterile PBS, as previously described (10). The optimal dose of Ag required to induce tolerance when injected into the thymus was determined in BALB/c mice by a dose-response experiment and found to be 100 µg of OVA (data not shown).

Preparation of thymocytes and staining for surface molecules

For staining of surface Ags, 5 x 105 of thymocytes suspended in PBS without Ca2+ and Mg2+ (Biowhittaker, Walkersville, MD) containing 1% BSA (Irvine, Santa Ana, CA) and 0.02% sodium azide (Sigma) were incubated with FITC- or PE-conjugated mAbs as indicated for 30 min on ice. After washing twice with 1 ml of PBS-sodium azide, the cells were resuspended in 0.5 ml of PBS-sodium azide.

Staining DNA of apoptotic cells with 7-AAD and flow cytometry analysis

Staining of apoptotic cells with 7-AAD was performed by the method described by Schmid et al. (16). Briefly, the thymocytes were prestained for surface Ag expression as above and then were incubated with 20 µg/ml of 7-AAD in PBS-sodium azide for 20 min at 4°C and protected from light. Cells were then analyzed on FACSort (Becton Dickinson, San Jose, CA) without further washing. A minimum of 10,000 events were collected and analyzed using Lysis II software (Becton Dickinson). Staining with 7-AAD differentiates between cells with 7-AADdim that are in the early stages of apoptosis and cells with 7-AADbright that are in the later stages of apoptosis (16). Thymocytes irradiated with 1200 rad and then incubated overnight at 37°C were used as positive controls for 7-AAD staining (16).

Cell cultures

Splenocytes (4 x 105 cells in 200 µl per well) were cultured in round-bottom microtiter plates (Costar, Cambridge, MA) and stimulated with OVA. Proliferation was measured by the standard 72-h lymphocyte proliferation assay. For cytokine production, thymocytes (8 x 105 cells in 200 µl per well) or splenocytes (4 x 105 cells in 200 µl per well) were cultured in X-Vivo serum-free medium (Biowhittaker). Cell-free supernatants were collected after 48 h for measurement of IL-2 and IFN-{gamma} production using both paired mAbs specific for the corresponding cytokine and purified recombinant murine cytokine according to the manufacturer’s recommendations (PharMingen, San Diego, CA). For IL-2 production by thymocytes, the measured IL-2 level was adjusted to the number of CD4+ cells as determined by staining with anti-CD4 and anti-CD8 Abs as above. In some experiments, rIL-2 (Boehringer Mannheim, Indianapolis, IN) was added to the cell cultures at a concentration of 5 U/ml to study reversal of unresponsiveness (10).


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Intrathymic injection of protein Ag induces apoptosis of thymocytes

To investigate whether acquired thymic tolerance is associated with apoptosis of Ag-specific T cells in the thymus, we used a method of staining with 7-AAD that labels apoptotic cells (16). First, thymocytes of OVA TCR-transgenic mice were collected 24 h after intrathymic injection of OVA or HEL, a nonspecific Ag control, and were stained with anti-CD4 and anti-CD8 mAbs followed by staining with 7-AAD. Thymocytes from naive mice served as a negative control, and irradiated cultured thymocytes served as a positive apoptosis control. Double positive (DP) or single positive (SP) cells were gated, and the percentage of 7-AAD positive cells in each population was determined (Fig. 1Go). In thymocytes from naive mice, 1 to 3% of DP cells and 1 to 5% of SP cells were 7-AAD+. This represents about 0.05 to 1% of total thymocytes that are undergoing apoptosis, consistent with previous reports (17). Intrathymic injection of control protein HEL did not alter the percentage of 7-AAD+ cells in either the DP or SP thymocytes compared with naive animals, although the total number of thymocytes and the number of DP cells were decreased, most likely because of the stress of surgery (Table IGoA). On the other hand, intrathymic injection of OVA resulted in a marked increase of apoptotic SP cells to 17.5 ± 2.5% 7-AAD+ cells of total SP cells, and of DP thymocytes to 10.6 ± 3% 7-AAD+ of total DP cells (Fig. 1Go). Most of the DP thymocytes in the OVA-injected animals that stained positive with 7-AAD showed bright staining (7-AADbright), indicating that they were in the later stages of apoptosis, while the 7-AAD+ SP thymocytes showed mostly dim staining for 7-AAD (7-AADdim), suggesting an earlier stage of apoptosis in this population (Fig. 1Go). When the number of thymocytes was determined, we found that by 24 h after intrathymic injection of OVA, the total number of DP T cells was dramatically decreased (by 73% compared with HEL-injected controls), whereas the number of SP T cells was only moderately reduced (by 30% compared with HEL-injected controls) (Table IGoA). Significant thymocyte apoptosis was not observed in animals injected systemically with the same dose of OVA (100 µg), but was detected in animals injected with a large dose of OVA (5 mg) (data not shown), as has been previously demonstrated (14, 15).



View larger version (32K):
[in this window]
[in a new window]
  		FIGURE 1. Thymocytes were stained with anti-CD4, anti-CD8, and 7-AAD. In A, CD4+CD8+ cells are gated and forward scatter is plotted against 7-AAD staining. In B, CD4+CD8- cells are gated and forward scatter is plotted against 7-AAD staining. 7-AAD staining is divided into bright (upper box) staining that indicates a later stage of apoptosis, and dim (lower box) staining that indicates an earlier stage of apoptosis. The numbers represent percentages of cells with 7-AADbright or 7-AADdim staining.

 

View this table:
[in this window]
[in a new window]
  		Table I. Change in numbers of thymocytes of OVA TCR-transgenic mice 24 h (A) and 7 days (B) after intrathymic Ag injection1

 
Surface staining of surface molecules on apoptotic thymocytes

Thymocytes from mice injected intrathymically with OVA were stained for CD4 and CD8 surface expression in combination with 7-AAD. CD4 expression of almost all early apoptotic 7-AADdim SP cells was significantly reduced. The mean fluorescence intensity of CD4 was markedly decreased compared with the 7-AAD- SP cells (Fig. 2Go). Similarly, 7-AADdim DP cells down-regulated their CD4 and CD8 expression (Fig. 2Go). These results indicate that apoptotic SP thymocytes down-regulate their CD4 expression in the process of apoptosis as previously reported for apoptotic DP thymocytes (18).



View larger version (23K):
[in this window]
[in a new window]
  		FIGURE 2. Down-regulation of CD4 expression on apoptotic thymocytes. Thymocytes were stained with CD4-PE, CD8-FITC, and 7-AAD. CD4+CD8+ (DP) and CD4+ (SP) thymocytes were gated, and each of the DP and SP populations was then gated according to its’ 7-AAD staining. Apoptotic cells (7-AAD+) had decreased expression of CD4 (filled histogram) compared with nonapoptotic (7-AAD-) cells (bold outline histogram). The background staining is shown in the stippled line histogram.

 
Kinetics of apoptosis induced by intrathymic injection of OVA

The decrease in number of DP cells 24 h after intrathymic injection of OVA (Table IGoA) suggested that apoptosis of this population may have been initiated earlier. Thus, we collected thymocytes at different time points after OVA injection. Positive staining with 7-AAD was detectable in DP thymocytes as early as 3 h after OVA injection. By 15 h after OVA injection, many DP cells were deleted and the remaining cells displayed a high percentage of 7-AADdim DP cells. By 24 h after OVA injection, more DP cells were 7-AADbright than 7-AADdim (Fig. 3Go), and this was associated with a remarkable decrease in live DP cells within the thymus (Table IGoA). In contrast, the SP thymocytes had no positive staining with 7-ADD until 15 h after intrathymic OVA injection. The peak of apoptosis, as determined by the highest percentage of 7-AADdim cells, occurred 24 h after intrathymic injection of OVA. By 48 h, the percentage of cells undergoing apoptosis began decreasing (Fig. 3Go). Interestingly, DP thymocytes decreased in number by 70% at 24 h and remained decreased by 67% on day 7, whereas SP cells decreased by 30% on day 1 and by 52% by day 7, when the percentage of cells undergoing apoptosis was close to the baseline level.



View larger version (17K):
[in this window]
[in a new window]
  		FIGURE 3. Kinetics of apoptosis in the thymus. Staining for 7-AAD is shown in the left panel for DP thymocytes and in the right panel for SP thymocytes. Staining was performed at different time points after intrathymic injection of HEL (open squares) or OVA (filled circles). Triangles represent naive animals. The results represent the mean of two to four experiments per time point.

 
Functional changes in T cells

We have previously shown that injection of OVA into the thymus of normal mice almost completely inhibits peripheral Th1 cell responses as determined by Ag proliferation and cytokine production (10). In this report, we found that a significant number of thymocytes in intrathymically injected animals do not undergo apoptosis. This would suggest that surviving thymocytes migrating to the periphery may be anergic. Thus, we measured IL-2 production by thymocytes after in vitro stimulation with OVA and found that IL-2 production in mice injected intrathymically with OVA was 10-fold lower than in HEL-injected mice (Fig. 4Go). IL-2 production was normalized by adjusting to the number of SP thymocytes in the culture because the cultures from OVA- or HEL-injected mice have different numbers of mature thymocytes. The results in Figure 4Go are reported as picograms per milliliter per million SP cells.



View larger version (11K):
[in this window]
[in a new window]
  		FIGURE 4. IL-2 production by thymocytes. Thymocytes were collected on day 14 after intrathymic injection from animals injected with OVA (filled circles) or HEL (open squares). Thymocytes were cultured at 8 x 105 cells/well in serum-free media with various concentrations of OVA as shown on the x-axis. Cell-free supernatants were collected 48 h later, and IL-2 production was measured by ELISA. The results were adjusted to the number of CD4+ cells and reported as pg/ml per 106 cells.

 
We investigated the functional characteristics of peripheral T cells of OVA TCR transgenics on day 7 after intrathymic injection of OVA. As seen in Figure 5Go, splenocyte proliferation and IL-2 production after OVA stimulation were suppressed, whereas IFN-{gamma} production was unchanged when compared with control HEL-injected mice. There was no evidence of deletion in the periphery; the total number of splenocytes, the number of CD4+ cells, and the percentage of CD4+ cells were all unchanged compared with HEL controls. Furthermore, there was no detectable staining with 7-AAD (data not shown). A time course study of splenocyte proliferation to OVA is shown in Figure 6Go; proliferation of splenocytes from animals injected intrathymically with OVA remains suppressed compared with that from animals injected intrathymically with HEL up to day 14 after intrathymic injection. Furthermore, the defects in proliferation and IL-2 production were not corrected by adding rIL-2 (5 U/ml) in the cultures (proliferation was 60–70% suppressed and IL-2 production was 50–70% suppressed compared with HEL over a range of Ag concentrations), as we have previously demonstrated for nontransgenic T cells (10).



View larger version (14K):
[in this window]
[in a new window]
  		FIGURE 5. Proliferation and cytokine production from splenocytes on day 7 after intrathymic injection. The open squares are cells from animals injected with HEL and the filled circles are cells from animals injected with OVA. Cells were pooled from three mice per group, proliferation was measured by [3H]thymidine incorporation, and cytokines were measured by ELISA in the cell-free supernatants. The x-axis represents the dose of OVA used in vitro. The y-axis is {Delta} cpm x 10-3 for proliferation and ng/ml for cytokines. The results shown are representative of three experiments.

 


View larger version (15K):
[in this window]
[in a new window]
  		FIGURE 6. Time course of proliferation of splenocytes. Splenocytes were isolated at various time points after intrathymic injection of OVA or HEL, and a standard proliferation assay was performed against OVA (25 mg/ml). The x-axis represents the time point when splenocytes were isolated, and the y-axis represents proliferative response in cpm x 10-3. The squares represent HEL-injected animals, and the filled circles represent OVA-injected animals.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
The thymus plays a major role in the development of self tolerance, but recently there has been a renewed interest in studying the role of the thymus in acquired tolerance. Over the past few years, several investigators published data indicating that injection of Ag into the thymus of adult animals leads to specific systemic tolerance in clinically relevant transplantation and autoimmune models (1, 2, 3, 4, 5, 6, 7, 8). More recently, Rooke et al. published data on intrathymic injection of adenoviral vectors indicating the potential for such an approach for gene therapy (19). However, the exact mechanisms responsible for the induction and maintenance of tolerance after intrathymic injection of Ag remain unclear. Understanding these mechanisms is essential for the clinical development of this strategy in humans as a treatment for autoimmune disease or to prevent rejection in organ transplantation (20). Our report is the first demonstration that intrathymic injection of Ag leads to Ag-specific thymocyte apoptosis in TCR-transgenic mice. Systemic injection of the same dose of Ag does not induce thymocyte apoptosis. This confirms the uniqueness of the intrathymic approach demonstrated in transplant and autoimmune models (1, 2, 3, 4, 5, 6, 7, 8). Our data are consistent with previous reports demonstrating that circulating whole protein Ag lead to deletion of CD4+ SP but not DP thymocytes (21), because only very high concentrations of "whole protein" can reach the thymic cortex through the blood-thymic barrier (22) or through a transcapsular route (23). The induction of CD4+ SP apoptosis by circulating protein occurs when the protein concentration in the serum reaches a threshold (21), while apoptosis of DP thymocytes occurs with systemic administration of "peptide" Ag (14). In the case of intrathymic injection of whole protein, we observed apoptosis in both populations of thymocytes, again indicating the uniqueness of the intrathymic approach. Oehen et al. used a pigeon cytochrome c TCR-transgenic mouse crossed with a transgenic mouse expressing pigeon cytochrome c in the thymus to study thymic selection, and showed apoptosis of DP and SP thymocytes (24). Additionally, unlike our model, their study showed decreased numbers of peripheral CD4+ cells associated with peripheral unresponsiveness (24). This different outcome (decrease in peripheral CD4+ T cells) is perhaps due to the presence of Ag in the thymus throughout development, while in our model the Ag is injected into a mature adult animal.

Our results also demonstrate that DP and SP thymocytes have different sensitivities to undergoing apoptosis after encounter with Ag presented by thymic APCs. DP cells start to become apoptotic earlier and a majority are ultimately deleted (14), whereas only a subset of SP thymocytes become apoptotic and do so later than DP thymocytes (21, 25). Furthermore, we show down-regulation of CD4R during apoptosis in SP cells. This was previously reported for DP (18) but not SP cells undergoing apoptosis.

Interestingly, peripheral T cells from intrathymically injected animals are anergic to stimulation with OVA, similar to our findings in nontransgenic BALB/c mice (10). Anergy of peripheral T cells is manifested by suppressed proliferation and decreased IL-2 production, but no effect on IFN-{gamma} production was evident. This is consistent with the described hierarchy of suppression for different lymphokines when T cells are anergized; IL-2 production being most affected, IL-3 less affected, and IFN-{gamma} the least affected (26, 27). In BALB/c mice, we showed the failure of peripheral Ag-specific T cell expansion after intrathymic injection of Ag (10). We also showed an increase in clonotype-positive T cells in the thymus after immunization, confirming that activated T cells circulate through the thymus. Furthermore, thymectomy after intrathymic injection abrogates the effect of acquired thymic tolerance and restores Ag-dependent clonal expansion in vivo (10). In the current study, we show that, similar to peripheral T cells, thymocytes from intrathymically tolerized transgenic animals are also anergic to stimulation with OVA. Interestingly, a small decrease in peripheral T cell proliferation (by 26%) can be seen as early as day 2 after intrathymic injection of OVA. This may be related to the exit of thymic dendritic cells or mature thymocytes that have been anergized in the thymus by exposure to Ag. The suppression of proliferation becomes maximal by day 7 (83%) after intrathymic injection of Ag, presumably as more peripheral T cells become anergic. These various lines of evidence demonstrate the pivotal role of the thymus in initiating and maintaining peripheral tolerance in this model.

In summary, intrathymic injection of Ag leads to tolerance of Ag-specific T cells. In TCR-transgenic mice, this tolerance is mediated by apoptosis of CD4+CD8+ and some CD4+ thymocytes within hours of intrathymic injection and by prolonged anergy of peripheral Ag-specific T cells in vivo. Peripheral T cell anergy may be mediated in part either by migration of anergic mature thymocytes that in turn anergize other T cells by a process of infectious tolerance (28) or by circulation of peripheral T cells to the thymus, where they are anergized (10). Alternatively, thymic dendritic cells may migrate out of the thymus and anergize peripheral T cells (9).

These data provide new information on the mechanisms of acquired thymic tolerance and may help in development of novel strategies to induce tolerance in autoimmunity and transplantation.


   Acknowledgments
 
We thank Drs. Abul Abbas, C. B. Carpenter, and L. A. Turka for critical review of the manuscript. We also thank Chang A. Kwok for expert technical assistance.


   Footnotes
 
1 Supported by research grants from the National Multiple Sclerosis Society (RG-2589-A-2 to S.J.K.) and the National Institutes of Health (AI-40945 to S.J.K. and AI-34965 to M.H.S.). Back

2 Current address: National Institutes of Health, Building 30, Room 3A-306, Laboratory of Immunology, 9000 Rockville Park, Bethesda, MD 20892. Back

3 M.H.S. is a recipient of the National Kidney Foundation Clinician Scientist Award. Back

4 Address correspondence and reprint requests to Dr. Samia J. Khoury, Center for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School, 77 Louis Pasteur Ave., Boston, MA 02115. E-mail address: Back

5 Abbreviations used in this paper: PE, phycoerythrin; HEL, hen egg lysozyme; 7-AAD, 7-amino-actinomycin D; DP, double positive; SP, single positive. Back

Received for publication September 16, 1997. Accepted for publication October 20, 1997.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Posselt, A. M., C. F. Barker, J. E. Tomaszewski, J. F. Markmann, M. A. Choti, A. Naji. 1990. Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science 249:1293.[Abstract/Free Full Text]
  2. Remuzzi, G., M. Rossini, O. Imberti, N. Perico. 1991. Kidney graft survival in rats without immunosuppressants after intrathymic glomerular transplantation. Lancet 337:750.[Medline]
  3. Naji, A.. 1996. Induction of tolerance by intrathymic inoculation of alloantigen. Curr. Opin. Immunol. 8:704.[Medline]
  4. Posselt, A. M., C. F. Barker, A. L. Friedman, A. Naji. 1992. Prevention of autoimmune diabetes in the BB rat by intrathymic islet transplantation at birth. Science 256:1321.[Abstract/Free Full Text]
  5. Koevary, S., M. Blomberg. 1992. Prevention of diabetes in BB/Wor rats by intrathymic islet injection. J. Clin. Invest. 89:512.
  6. Gerling, I. C., D. V. Serreze, S. W. Christianson, E. H. Leiter. 1992. Intrathymic islet cell transplantation reduces ß-cell autoimmunity and prevents diabetes in NOD/Lt mice. Diabetes 41:1672.[Abstract]
  7. Khoury, S. J., M. H. Sayegh, W. W. Hancock, L. Gallon, C. B. Carpenter, H. L. Weiner. 1993. Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide. J. Exp. Med. 178:559.[Abstract/Free Full Text]
  8. Goss, J. A., Y. Nakafusa, C. R. Roland, W. F. Hickey, M. W. Flye. 1994. Immunological tolerance to a defined myelin basic protein antigen administered intrathymically. J. Immunol. 153:3890.[Abstract]
  9. Khoury, S. J., L. Gallon, W. Chen, K. Betres, M. E. Russell, W. W. Hancock, C. B. Carpenter, M. H. Sayegh, H. L. Weiner. 1995. Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo. J. Exp. Med. 182:357.[Abstract/Free Full Text]
  10. Chen, W., S. Issazadeh, M. H. Sayegh, S. J. Khoury. 1997. In vivo mechanisms of acquired thymic tolerance. Cell Immunol. 179:165.[Medline]
  11. Markmann, J. F., J. S. Odorico, H. Bassiri, N. M. Desai, J. Kim, C. F. Barker. 1993. Deletion of donor-reactive T lymphocytes in adult mice after intrathymic inoculation with lymphoid cells. Transplantation 55:871.[Medline]
  12. Remuzzi, G., M. Noris, A. Benigni, O. Imberti, M. H. Sayegh, N. Perico. 1994. Thromboxane A2 receptor blocking abrogates donor-specific unresponsiveness to renal allografts induced by thymic recognition of major histocompatibility allopeptides. J. Exp. Med. 180:1967.[Abstract/Free Full Text]
  13. Sayegh, M. H., N. Perico, L. Gallon, O. Imberti, W. W. Hancock, G. Remuzzi, C. B. Carpenter. 1994. Mechanisms of acquired thymic unresponsiveness to renal allografts: thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy. Transplantation 58:125.[Medline]
  14. Murphy, K. M., A. B. Heimberger, D. Y. Loh. 1990. Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science 250:1720.[Abstract/Free Full Text]
  15. Liblau, R. S., R. Tisch, K. Shokat, X.-D. Yang, N. Dumont, C. C. Goodnow, H. O. McDevitt. 1996. Intravenous injection of soluble antigen induces thymic and peripheral T-cell apoptosis. Proc. Natl. Acad. Sci. USA 93:3031.[Abstract/Free Full Text]
  16. Schmid, I., C. H. Uittenbogaart, B. Keld, J. V. Giorgi. 1994. A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. J. Immunol. Methods 170:145.[Medline]
  17. Surh, C. D., J. Sprent. 1994. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372:100.[Medline]
  18. Page, D. M., L. P. Kane, J. P. Allison, S. M. Hedrick. 1993. Two signals are required for negative selection of CD4+CD8+ thymocytes. J. Immunol. 151:1868.[Abstract]
  19. Rooke, R., C. Waltzinger, C. Benoist, D. Mathis. 1997. Targeted complementation of MHC class II deficiency by intrathymic delivery of recombinant adenoviruses. Immunity 7:123.[Medline]
  20. Sayegh, M. H.. 1994. Applicability of acquired thymic unresponsiveness in humans. J. Nephrol. 7:3.
  21. Zal, T., A. Volkman, B. Stockinger. 1994. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. J. Exp. Med. 180:2089.[Abstract/Free Full Text]
  22. Sprent, J., S. R. Webb. 1995. Intrathymic and extrathymic clonal deletion of T cells. Curr. Opin. Immunol. 7:196.[Medline]
  23. Nieuwenhuis, P., R. J. M. Stet, J. P. A. Wegenaar, A. S. Wubbena, J. Kampinga, A. Karrenbeld. 1988. The transcapsular route: a new way for (self) antigens to by-pass the blood-thymus barrier. Immunol. Today 9:372.[Medline]
  24. Oehen, S., L. Feng, Y. Xia, C. D. Surh, S. M. Hedrick. 1996. Antigen compartmentation and T helper cell tolerance induction. J. Exp. Med. 183:2617.[Abstract/Free Full Text]
  25. Liu, G. Y., P. J. Fairchild, R. M. Smith, J. R. Prowle, D. Kioussis, D. C. Wraith. 1995. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 3:407.[Medline]
  26. Jenkins, M. K., C. Chen, G. Jung, D. L. Mueller, R. H. Schwartz. 1990. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J. Immunol. 144:16.[Abstract]
  27. Beverly, B., S.-M. Kang, M. J. Lenardo, R. H. Schwartz. 1992. Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int. Immunol. 4:661.[Abstract/Free Full Text]
  28. Qin, S., S. Cobbold, H. Pope, J. Elliott, D. Kioussis, J. Davies, H. Waldmann. 1993. "Infectious" transplantation tolerance. Science 259:974.[Abstract]



This article has been cited by other articles:


Home page
 J. Immunol.Home page
F. Song, Z. Guan, I. E. Gienapp, T. Shawler, J. Benson, and C. C. Whitacre
The Thymus Plays a Role in Oral Tolerance in Experimental Autoimmune Encephalomyelitis
J. Immunol., August 1, 2006; 177(3): 1500 - 1509.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
Y. Okura, Y. Jee, and Y. Matsumoto
Acquired thymic tolerance to autoimmune encephalomyelitis is associated with activation of peripheral IL-10-producing macrophages/dendritic cells
Int. Immunol., March 1, 2003; 15(3): 437 - 446.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
W. Chen, W. Jin, H. Tian, P. Sicurello, M. Frank, J. M. Orenstein, and S. M. Wahl
Requirement for Transforming Growth Factor {beta}1 in Controlling T Cell Apoptosis
J. Exp. Med., August 20, 2001; 194(4): 439 - 454.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Deng, E. Goluszko, and P. Christadoss
Fas/Fas Ligand Pathway, Apoptosis, and Clonal Anergy Involved in Systemic Acetylcholine Receptor T Cell Epitope Tolerance
J. Immunol., March 1, 2001; 166(5): 3458 - 3467.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
A.-C. Field, L. Caccavelli, J. Fillion, J. Kuhn, C. Mandet, P. Druet, and B. Bellon
Neonatal induction of tolerance to Th2-mediated autoimmunity in rats
Int. Immunol., October 1, 2000; 12(10): 1467 - 1477.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Aiello, M. Noris, G. Piccinini, S. Tomasoni, F. Casiraghi, S. Bonazzola, M. Mister, M. H. Sayegh, and G. Remuzzi
Thymic Dendritic Cells Express Inducible Nitric Oxide Synthase and Generate Nitric Oxide in Response to Self- and Alloantigens
J. Immunol., May 1, 2000; 164(9): 4649 - 4658.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Khanna, A. E. Morelli, C. Zhong, T. Takayama, L. Lu, and A. W. Thomson
Effects of Liver-Derived Dendritic Cell Progenitors on Th1- and Th2-Like Cytokine Responses In Vitro and In Vivo
J. Immunol., February 1, 2000; 164(3): 1346 - 1354.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Issazadeh, M. Zhang, M. H. Sayegh, and S. J. Khoury
Acquired Thymic Tolerance: Role of CTLA4 in the Initiation and Maintenance of Tolerance in a Clinically Relevant Autoimmune Disease Model
J. Immunol., January 15, 1999; 162(2): 761 - 765.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, W.
Right arrow Articles by Khoury, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, W.
Right arrow Articles by Khoury, S. J.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS